| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analytical and clinical evaluation of biomarkers assays: When are biomarkers ready for prime time?
|
Pennello, Gene A
|
|
2013
|
10 |
5 |
p. 666-676
|
artikel
|
| 2 |
An audit strategy for time-to-event outcomes measured with error: Application to five randomized controlled trials in oncology
|
Dodd, Lori E
|
|
2013
|
10 |
5 |
p. 754-760
|
artikel
|
| 3 |
Application of methods for central statistical monitoring in clinical trials
|
Kirkwood, Amy A
|
|
2013
|
10 |
5 |
p. 783-806
|
artikel
|
| 4 |
Assessment of biomarkers for risk prediction with nested case–control studies
|
Zhou, Qian M
|
|
2013
|
10 |
5 |
p. 677-679
|
artikel
|
| 5 |
Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials
|
Berry, Scott M
|
|
2013
|
10 |
5 |
p. 720-734
|
artikel
|
| 6 |
Clinical trial participation improves outcome: A matched historical cohort study
|
Baker, John R
|
|
2013
|
10 |
5 |
p. 735-743
|
artikel
|
| 7 |
Development of omics-based clinical tests for prognosis and therapy selection: The challenge of achieving statistical robustness and clinical utility
|
McShane, Lisa M
|
|
2013
|
10 |
5 |
p. 653-665
|
artikel
|
| 8 |
Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study
|
Connor, Jason T
|
|
2013
|
10 |
5 |
p. 807-827
|
artikel
|
| 9 |
Feasibility trial of a Spanish-language multimedia educational intervention
|
Wells, Kristen J
|
|
2013
|
10 |
5 |
p. 767-774
|
artikel
|
| 10 |
How good does the science have to be in proposals submitted to Institutional Review Boards? An Interview Study of Institutional Review Board personnel
|
Klitzman, Robert
|
|
2013
|
10 |
5 |
p. 761-766
|
artikel
|
| 11 |
Imperfect gold standards for biomarker evaluation
|
Waikar, Sushrut S
|
|
2013
|
10 |
5 |
p. 696-700
|
artikel
|
| 12 |
Inference from blinded data in randomized clinical trials
|
Zhou, Kefei
|
|
2013
|
10 |
5 |
p. 744-753
|
artikel
|
| 13 |
Integrating biomarker information within trials to evaluate treatment mechanisms and efficacy for personalised medicine
|
Dunn, Graham
|
|
2013
|
10 |
5 |
p. 709-719
|
artikel
|
| 14 |
Proceedings of the University of Pennsylvania 5th annual conference on statistical issues in clinical trials: Emerging statistical issues in biomarker validation for clinical trials
|
Ellenberg, Jonas H
|
|
2013
|
10 |
5 |
p. 645-646
|
artikel
|
| 15 |
Reconnecting with urban youth enrolled in a randomized controlled trial and overdue for a 12-month follow-up survey
|
Ezell, Jerel M
|
|
2013
|
10 |
5 |
p. 775-782
|
artikel
|
| 16 |
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity
|
Qu, Yongming
|
|
2013
|
10 |
5 |
p. 693-695
|
artikel
|
| 17 |
Statistical issues in the validation of prognostic, predictive, and surrogate biomarkers
|
Sargent, Daniel J
|
|
2013
|
10 |
5 |
p. 647-652
|
artikel
|
| 18 |
Testing the incremental predictive accuracy of new markers
|
Begg, Colin B
|
|
2013
|
10 |
5 |
p. 690-692
|
artikel
|
| 19 |
University of Pennsylvania 5th annual conference on statistical issues in Clinical Trials: Emerging statistical issues in biomarker validation (afternoon session)
|
Rubin, Eric
|
|
2013
|
10 |
5 |
p. 701-708
|
artikel
|
| 20 |
University of Pennsylvania 5th annual conference on statistical issues in clinical trials: Emerging statistical issues in biomarker validation (Morning Session)
|
DeMets, David
|
|
2013
|
10 |
5 |
p. 680-689
|
artikel
|
Tijdschrift beschrijving